Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 15.45
+0.20 (1.31%)
Feb 3, 2026, 2:55 PM CST
SHE:300601 Market Cap
SHE:300601 has a market cap or net worth of 17.03 billion as of February 2, 2026. Its market cap has decreased by -5.86% in one year.
Market Cap
17.03B
Enterprise Value
17.25B
Revenue
2.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
15.45
Market Cap Chart
Since February 7, 2017, SHE:300601's market cap has increased from 1.95B to 17.03B, an increase of 774.33%. That is a compound annual growth rate of 27.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 17.03B | 3.25% |
| Dec 31, 2025 | 16.50B | -13.88% |
| Dec 31, 2024 | 19.16B | -36.83% |
| Dec 29, 2023 | 30.32B | 11.35% |
| Dec 30, 2022 | 27.23B | -59.77% |
| Dec 31, 2021 | 67.70B | -43.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Double-Crane Pharmaceutical | 19.37B |
| Shandong Buchang Pharmaceuticals | 17.94B |
| Tonghua Dongbao Pharmaceutical | 17.59B |
| Hybio Pharmaceutical | 16.70B |
| Shenzhen Hepalink Pharmaceutical Group | 16.51B |
| Guangdong Zhongsheng Pharmaceutical | 16.28B |
| Zhejiang Jiuzhou Pharmaceutical | 16.08B |
| Fujian Cosunter Pharmaceutical | 15.87B |